Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Ali Pate, the most common co-covered peer. We currently track 1 Biotech story that mention Dr Paul Ogwuche, all published on August 12, 2026.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Ali Pate, the most common co-covered peer. We currently track 1 Biotech story that mention Dr Paul Ogwuche, all published on August 12, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr Paul Ogwuche. Shared-story counts are live from our verified record — not editorial picks.
The Federal Government donated 100 vials of Panaf Premium anti-snake venom worth N25m to Benue State, underscoring procurement and distribution dynamics in Nigeria's antivenom market. For biopharma stakeholders, the consignment highlights unit economics and access barriers in neglected tropical disease therapeutics.
Source: tribuneonlineng.com · dailytrust.com
Dr Paul Ogwuche is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
